171 related articles for article (PubMed ID: 38164168)
1. Combination of TrxR1 inhibitor and lenvatinib triggers ROS-dependent cell death in human lung cancer cells.
Zheng P; Xia Y; Shen X; Lu H; Chen Y; Xu C; Qiu C; Zhang Y; Zou P; Cui R; Huang X
Int J Biol Sci; 2024; 20(1):249-264. PubMed ID: 38164168
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo.
Fan C; Zheng W; Fu X; Li X; Wong YS; Chen T
Cell Death Dis; 2014 Apr; 5(4):e1191. PubMed ID: 24763048
[TBL] [Abstract][Full Text] [Related]
3. Synergistic targeting of TrxR1 and ATM/AKT pathway in human colon cancer cells.
Shen X; Xia Y; Lu H; Zheng P; Wang J; Chen Y; Xu C; Qiu C; Zhang Y; Xiao Z; Zou P; Cui R; Ni D
Biomed Pharmacother; 2024 May; 174():116507. PubMed ID: 38565059
[TBL] [Abstract][Full Text] [Related]
4. Inducing ubiquitination and degradation of TrxR1 protein by LW-216 promotes apoptosis in non-small cell lung cancer via triggering ROS production.
Wang R; Zhong L; Wang T; Sun T; Yang J; Liu X; Wu Y; Guo Q; Gao Y; Zhao K
Neoplasia; 2024 Jul; 53():101004. PubMed ID: 38733769
[TBL] [Abstract][Full Text] [Related]
5. p53-dependent inhibition of TrxR1 contributes to the tumor-specific induction of apoptosis by RITA.
Hedström E; Eriksson S; Zawacka-Pankau J; Arnér ES; Selivanova G
Cell Cycle; 2009 Nov; 8(21):3584-91. PubMed ID: 19838062
[TBL] [Abstract][Full Text] [Related]
6. Menadione Potentiates Auranofin-Induced Glioblastoma Cell Death.
Szeliga M; Rola R
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555352
[TBL] [Abstract][Full Text] [Related]
7. Thimerosal, a competitive thioredoxin reductase 1 (TrxR1) inhibitor discovered via high-throughput screening.
Ni Y; Luo Z; Lv Y; Ma S; Luo C; Du D
Biochem Biophys Res Commun; 2023 Apr; 650():117-122. PubMed ID: 36780763
[TBL] [Abstract][Full Text] [Related]
8. Cystatin SN inhibits auranofin-induced cell death by autophagic induction and ROS regulation via glutathione reductase activity in colorectal cancer.
Oh BM; Lee SJ; Cho HJ; Park YS; Kim JT; Yoon SR; Lee SC; Lim JS; Kim BY; Choe YK; Lee HG
Cell Death Dis; 2017 Mar; 8(3):e2682. PubMed ID: 28300829
[TBL] [Abstract][Full Text] [Related]
9. Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer.
Zhang H; Wu J; Yuan J; Li H; Zhang Y; Wu W; Chen W; Wang C; Meng S; Chen S; Huo M; He Y; Zhang C
J Exp Clin Cancer Res; 2021 Aug; 40(1):260. PubMed ID: 34412665
[TBL] [Abstract][Full Text] [Related]
10. High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy.
Eriksson SE; Prast-Nielsen S; Flaberg E; Szekely L; Arnér ES
Free Radic Biol Med; 2009 Dec; 47(11):1661-71. PubMed ID: 19766715
[TBL] [Abstract][Full Text] [Related]
11. Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia.
Fiskus W; Saba N; Shen M; Ghias M; Liu J; Gupta SD; Chauhan L; Rao R; Gunewardena S; Schorno K; Austin CP; Maddocks K; Byrd J; Melnick A; Huang P; Wiestner A; Bhalla KN
Cancer Res; 2014 May; 74(9):2520-32. PubMed ID: 24599128
[TBL] [Abstract][Full Text] [Related]
12. EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells.
Zou P; Xia Y; Chen W; Chen X; Ying S; Feng Z; Chen T; Ye Q; Wang Z; Qiu C; Yang S; Liang G
Oncotarget; 2016 Apr; 7(14):18050-64. PubMed ID: 26919110
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of thioredoxin and its reductase attenuates arsenic trioxide‑induced growth suppression in human pulmonary artery smooth muscle cells by reducing oxidative stress.
Park WH
Oncol Rep; 2020 Jan; 43(1):358-367. PubMed ID: 31789420
[TBL] [Abstract][Full Text] [Related]
14. Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose.
Du Y; Zhang H; Lu J; Holmgren A
J Biol Chem; 2012 Nov; 287(45):38210-9. PubMed ID: 22977247
[TBL] [Abstract][Full Text] [Related]
15. Piperlongumine potentiates the antitumor efficacy of oxaliplatin through ROS induction in gastric cancer cells.
Zhang P; Shi L; Zhang T; Hong L; He W; Cao P; Shen X; Zheng P; Xia Y; Zou P
Cell Oncol (Dordr); 2019 Dec; 42(6):847-860. PubMed ID: 31493144
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer.
Raninga PV; Lee AC; Sinha D; Shih YY; Mittal D; Makhale A; Bain AL; Nanayakarra D; Tonissen KF; Kalimutho M; Khanna KK
Int J Cancer; 2020 Jan; 146(1):123-136. PubMed ID: 31090219
[TBL] [Abstract][Full Text] [Related]
17. Selective killing of gastric cancer cells by a small molecule via targeting TrxR1 and ROS-mediated ER stress activation.
Chen W; Zou P; Zhao Z; Weng Q; Chen X; Ying S; Ye Q; Wang Z; Ji J; Liang G
Oncotarget; 2016 Mar; 7(13):16593-609. PubMed ID: 26919094
[TBL] [Abstract][Full Text] [Related]
18. KEAP1-dependent synthetic lethality induced by AKT and TXNRD1 inhibitors in lung cancer.
Dai B; Yoo SY; Bartholomeusz G; Graham RA; Majidi M; Yan S; Meng J; Ji L; Coombes K; Minna JD; Fang B; Roth JA
Cancer Res; 2013 Sep; 73(17):5532-43. PubMed ID: 23824739
[TBL] [Abstract][Full Text] [Related]
19. Auranofin induces mesothelioma cell death through oxidative stress and GSH depletion.
You BR; Park WH
Oncol Rep; 2016 Jan; 35(1):546-51. PubMed ID: 26530353
[TBL] [Abstract][Full Text] [Related]
20. Plumbagin reduction by thioredoxin reductase 1 possesses synergy effects with GLUT1 inhibitor on KEAP1-mutant NSCLC cells.
Sun S; Zhang Y; Xu W; Yang R; Yang Y; Guo J; Ma Q; Ma K; Zhang J; Xu J
Biomed Pharmacother; 2022 Feb; 146():112546. PubMed ID: 34954641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
